GGrantIndex
← Search

DOSE ESCALATION STUDY FOR THE ANTIBODY MT102 (ANTI CPCAMXANTI-CD3)

$3,193P51FY2003RRNIH

Southwest Foundation For Biomedical Res, San Antonio TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →